Marc Robillard, Tagworks Pharmaceuticals CEO
Tagworks lands $65M for its take on Nobel-winning click chemistry in bid to expand ADC, radiopharma potential
A Dutch-American biotech is out with $65 million in Series A funding to get into the clinic with what it calls an expanded scope of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
